Mizuho Markets Americas’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,584,719
Closed -$158M 180
2025
Q1
$158M Buy
2,584,719
+5,119
+0.2% +$298K 3.24% 8
2024
Q4
$146M Hold
2,579,600
2.61% 10
2024
Q3
$133M Sell
2,579,600
-220,000
-8% -$10.3M 2.76% 10
2024
Q2
$116M Buy
2,799,600
+2,579,600
+1,173% +$115M 2.79% 9
2024
Q1
$11.9M Buy
+220,000
New +$11.2M 0.29% 52
2023
Q4
Sell
-1,419,795
Closed -$82.4M 173
2023
Q3
$82.4M Buy
+1,419,795
New +$87M 2.88% 9
2023
Q2
Sell
-1,739,189
Closed -$121M 47
2023
Q1
$121M Buy
1,739,189
+985,756
+131% +$69.5M 4.85% 7
2022
Q4
$54.2M Buy
+753,433
New +$56.8M 3.2% 8

Other funds holding BMY

Mizuho Markets Americas's BMY Position: Q2 2025 in Review

Mizuho Markets Americas sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 2,584,719 shares — an estimated $158M sold.

Mizuho Markets Americas first reported a position in BMY in Q4 2022 and held it in 8 quarters. The position peaked at $158M in Q1 2025. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Mizuho Markets Americas reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Mizuho Markets Americas sold 2,584,719 Bristol-Myers Squibb shares in Q2 2025, an estimated $158M.
  • Mizuho Markets Americas first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 8 quarters.
  • Mizuho Markets Americas's Bristol-Myers Squibb position peaked at $158M in Q1 2025.
  • 2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Mizuho Markets Americas's 13F filing for Q2 2025, filed 1 Aug 2025.